INTRODUCTION
Human cytomegalovirus (HCMV) is an opportunistic pathogen that causes severe disease complications and pathogenesis in immunocompromised individuals. HCMV infection of newborns often results in cytomegalic inclusion disease. During the lytic cycle of HCMV infection, viral genes are expressed in a regulated cascade pattern with immediate-early (IE), early, and late gene expression. Among the IE proteins, the 86-kDa IE2 (also called IE86 or IE2-p86) has various activities, as a strong transactivator of viral and cellular genes, as a repressor of its own major IE (MIE) promoter, and as a cell cycle modulator (41).
The multiple functions of IE2 are attributed to its ability to interact with numerous cellular proteins. IE2 has been shown to interact with components of the basal transcription factor complex, including TFIIB, TBP, and TBP-associated factors (TAFs) such as TAFII110 and TAFII130 (11, 15, 19, 25, 29, 36, 37, 57) . IE2 also interacts with numerous transcription factors such as Ap-1, Sp1, Egr-1, CREB, CBP, SP1-1/Pu.1, Tef-1, and P/CAF (10, 31, 37, 54, 55, 64, 66, 68) , as well as with histone modifiers such as HDAC1, HDAC2, HDAC3, G9a, and Suvar(3-9)H1 (43, 45, 50). IE2 also binds to cell cycle modulators such as RB (13, 14, 18, 57) , p53 (8, 60, 62) , and MDM2 (69).
IE2 is covalently modified by the small ubiquitin-like modifiers (SUMO)-1, SUMO-2, and SUMO-3 at two lysine residues (K175 and K180), and SUMOylation of IE2 enhances its transactivation capacity for diverse cellular and viral promoters (5, 22) . Analysis of the amino acid variations of IE2 in different HCMV strains has consistently demonstrated a correlation between the transactivation activity of IE2 and its degree of SUMOylation (6) . However, IE2 SUMOylation has not been shown to be essential for viral growth, since a mutant virus encoding K175/180R mutant IE2, which is defective in SUMOylation, was still viable, although the impact of the absence of IE2 on July 8, 2017 by guest http://jvi.asm.org/
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SUMOylation on viral replication was dependent on virus strains (7, 32 ). IE2 has also been shown to directly bind to Ubc9, a SUMO E2 conjugating enzyme (5, 22) , and PIAS1, a SUMO E3 ligase (35).
In addition to covalent SUMO attachment, proteins can also non-covalently interact with SUMO through a region of so-called SUMO-interacting motifs (SIMs). Several studies have identified hydrophobic amino acid residues flanked by negatively charged residues, including h-h-X-S-X-S/T-a-a-a (h, hydrophobic; a, acidic; X, any amino acid) or I/V-X-I/V-I/V, as SIM consensus sequences (20, 27, 40, 58) . SIMs in certain proteins have been found to mediate protein SUMOylation, in addition to being also involved in mediating interactions with other SUMOmodified proteins (27) . IE2 also contains a region that resembles a SIM near the SUMO modification sites (5, 7) . However, the role of the IE2 SIM in virus infection is not clear.
In this study, we show that the SIM of IE2 is required for the transactivation function of IE2.
Analysis of the IE2 SIM mutant virus provides genetic evidence that non-covalent SUMO binding by IE2 is necessary for efficient viral gene expression and lytic growth by promoting the association of IE2 with viral promoters in viral transcription sites. We also show that IE2 interacts with the SUMO-modified form of TBP-associated factor (TAF) 12, a component of the TFIID complex, in a SIM-dependent manner, and that this interaction enhances the transactivation capacity of IE2.
MATERIALS AND METHODS
Cell culture, production of virus stocks, and transfection. Human foreskin fibroblast (HF) cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. The IE2(K175/180R) mutant virus (Towne) and its revertant were previously described (32). IE1-on July 8, 2017 by guest http://jvi.asm.org/ Downloaded from expressing HF cells (33) were used to grow the IE2 mSIM and KR/mSIM viruses to high titers. Viral titers were determined on HF cells using infectious center assays employing an anti-IE1 Ab (23) .
Electroporation of HF cells was conducted using a Microporator MP-100 (Digital Bio), as previously described (23) .
Plasmids. The IE2 expression plasmids were generated with the IE2 cDNA derived from the Towne strain of CMV. pSG5-based expression plasmids for wild-type (pJHA124) and K175/180R IE2 (pYX104) have been previously described (5) . Plasmids expressing the IE2 SIM mutants (mSIM and KR/mSIM) were generated on pJHA124 and pYX104 backgrounds, respectively, by substituting I, V, I, and S residues between 200 and 203 to A residues using the Stratagene QuickChange site-directed mutagenesis protocol. Plasmids expressing the HA-tagged or myc-tagged versions of IE2 were also generated on a pSG5 background using Gateway technology (Invitrogen). Plasmids for glutathione-S-transferase (GST)-IE2(135-289) and its SIM mutant version were constructed on a pGEX-3X-derived vector. The plasmid for His-SUMO-1 was generated on a pDEST17 (Invitrogen) background. A pET-17b (Novagen)-based plasmid expressing SUMO-1 has been described previously (Kim et al, 2009) . A reporter plasmid containing the HCMV UL54-luciferase (Pol-Luc) reporter gene was previously described (5) . A reporter plasmid containing the UL112-113-luciferase (UL112-113-Luc) (22) was provided by Thomas Stamminger (University Erlangen-Nurnberg, Erlangen, Germany). pT-E1E2S1, which expresses E1, E2, and an active form of SUMO-1, was used to introduce a synthetic SUMO-1 conjugation pathway into E. coli (63) . Plasmids for His-or HA-tagged TAF12 (20-kDa) were provided by Robert G. Roeder (The Rockefeller University, New York, NY) and Thomas Oelgeschlager (Marie Curie Research Institute, Oxted, United Kingdom) (9, 21) . Plasmids expressing HA-tagged TAF12, TAF12(K19R), or SUMO-1-TAF12 fusion proteins and -TAF12 or GST-SUMO-1-TAF12 were produced on pSG5 and pGEX-3X backgrounds, respectively, using Gateway technology. The GST-IE1 construct was described previously (26).
Bacterial artificial chromosome (BAC) mutagenesis. The Towne-BAC (T-BAC) clone (38) was used as a template for mutagenesis. A 4.1-kb PvuII-SalI restriction fragment containing the wildtype UL122-UL123 allele from the Towne strain and a 2.4-kb BglII-StuI restriction fragment containing the IE2(K175/180R) allele were cloned into the transfer vector, pGS284, a derivative of the positive suicide selection vector (pCV442) (38), and these resulted in pHR8 and pSAN2, respectively. To mutate the IE2 SIM, I, V, I, and S residues between 200 and 203 were substituted by A residues on pHR8 and pSAN2 backgrounds using the Stratagene QuickChange site-directed mutagenesis protocol, resulting in pYH69 and pYH56, respectively. These plasmids were used as transfer vectors. The subsequent procedures for transfer of DNA fragments containing the SIM mutation into E. coli containing the T-BAC clone, and for selection of the cointegrates and the mutant T-BAC clones, were described previously (23) . The mutant T-BAC clones containing the IE2-mSIM and the IE2-KR/mSIM mutations were pYH72 and pYH70, respectively. Their revertant T-BAC clones (pYH76 and pYH75, respectively) were generated by the allelic exchange of the mutants using a transfer vector (pHR8) containing the wild-type fragment. The T-BAC clone containing the IE2-K175/180R mutant (pBAC2) and its revertant clone (pHR14) were described previously (32). The SIM mutation and its reversion to wild-type in the T-BAC clones were confirmed by direct sequencing and by comparing their restriction enzyme patterns using gel electrophoresis, as described previously (23) . and IE2, and mouse MAb 6E1, which is specific to IE1, were obtained from Chemicon and Vancouver Biotech, respectively. Anti-peptide rabbit polyclonal Ab (PAb) P3 for IE2 was previously described (48). Anti-myc mouse MAb 9E10 conjugated with peroxidase was purchased from Roche.
Mouse MAb M23 and rabbit PAb against the UL112-113 proteins were described previously (46), Mouse MAbs against p52 (UL44) and pp28 (UL99) were obtained from Virusys. Rabbit anti-peptide PAb referred to as PML(C), directed against amino acids 484 to 498 of PML, was described previously (2) . Anti-HDAC2 rabbit PAb and anti-β-actin mouse MAb were purchased from Zymed and Sigma, respectively. Anti-His mouse MAb conjugated with HRP and anti-GST mouse MAb (B-14) were purchased from Santa Cruz. Anti-RNA polymerase II MAb (8WG16) was purchased from Covance.
For indirect immunofluorescence assay (IFA), cells were fixed in ice-cold methanol and rehydrated in cold Tris-buffered saline (TBS), or fixed with 1% paraformaldehyde and permeabilized using 0.2% Triton X-100. All subsequent procedures were described previously (5).
Slides were examined and photographed using a Zeiss Axiophot microscope. For confocal microscopy, a Carl Zeiss Axioplan 2 confocal microscope system with LSM510 software (Carl Zeiss) was used.
Immunoblot analysis. For immunoblot analysis, DNA-transfected cells were washed with phosphate-buffered saline (PBS) and total cell extracts were prepared by boiling the cell pellets in sodium dodecyl sulfate (SDS) loading buffer. Equal amounts of the clarified cell extracts were on July 8, 2017 by guest http://jvi.asm.org/ Downloaded from separated on a SDS-8% or 12% polyacrylamide gels, and were subjected to a standard enhanced chemiluminescence system procedure (Amersham).
In vitro binding assays. The GST, GST-fusion, SUMO-1, and His-SUMO-1 proteins were generated in E. coli. The myc-IE2 proteins were synthesized in vitro using the TNT Quick-Coupled transcription/translation system (Promega). The standard procedure for the GST pull-down assays was described previously (45). The SUMO-1-modified and unmodified His-TAF12 or GST-IE1 proteins were produced by the E. coli SUMOylation system using pT-E1E2S1 (63) .
Coimmunoprecipitation assays using these proteins were performed with anti-myc antibody as described previously (23) .
Luciferase reporter assay. For luciferase reporter assays, electroporated HF cells were collected and cell lysates were prepared using three freeze-thaw steps in 100 µl of 0.25 M Tris-HCl (pH 7.9) plus 1 mM dithiothreitol. Subsequent procedures were previously described (5) . A TD-20/20 luminometer (Turner Designs) was used to measure light output (in relative light units) for the 10 sec assay. 
Chromatin immunoprecipitation

RESULTS
Interaction of IE2 with SUMO and defining the IE2 SIM.
A predicted SIM of HCMV IE2 was found between amino acid residues 200 and 208 (IVISDEEE) near the SUMO modification sites (K175 and K180) ( Untagged and His-tagged SUMO-1 was also produced in E. coli. The results of GST pull-down assays showed that the wild-type IE2 fragment efficiently bound to His-SUMO-1, whereas the mSIM IE2 did not interact with SUMO at all (Fig. 1B) . When a competition assay was performed under the same reaction conditions, the addition of increasing amounts of untagged SUMO-1 (KR) mutant defective in SUMOylation, a SIM mutant (mSIM), and a KR/mSIM mutant containing both KR and mSIM mutations, and the localization patterns were determined by indirect IFA. The results showed that, consistent with our earlier observation (32), the KR mutant protein was distributed in a pattern similar to the wild-type protein, forming foci that colocalize with PML-NBs, whereas both mSIM and KR/mSIM mutants did not form foci at all, but were just distributed in a nuclear diffuse form (Fig. S1 ). Considering that SUMO-modified proteins are highly concentrated in PML-NBs, these results suggest that the IE2 SIM may provide a surface for interactions with other SUMO-modified proteins.
IE2 SIM is required for efficient transactivation function.
SUMOylation of IE2 enhanced its transactivation capacity for several viral and cellular promoters (5, 22, 35) . However, our previous studies using a Towne strain-based recombinant virus, which encodes the K175/180R (KR) mutant IE2, which is defective in SUMOylation, demonstrated that IE2 SUMOylation is not essential for viral replication in permissive HF cells (32). Notably, two 1 1 SUMO modification sites, K174 and K180, are located beyond the region that was previously mapped and identified as necessary for the transactivation function of IE2 (1, 48, 49); however, the IE2 SIM lies within this region (Fig. 1A) . We examined the role of the IE2 SIM in IE2 transactivation function. The results of reporter assays performed in HF cells showed that, consistent with our earlier observation (5), the IE2 KR mutant transactivated the viral UL112-113
and polymerase (UL54) promoters to similar or just marginally-reduced levels as wild-type IE2 in a situation where SUMO is not overexpressed ( Fig. 2A) . However, the SIM mutants of IE2, either mSIM or KR/mSIM, showed significantly reduced levels of transactivation activity for these promoters compared to wild-type ( Fig. 2A) . The results of ChIP assays performed in similarly transfected cells, showed that cellular RNA polymerase II was less efficiently recruited to the viral polymerase promoter in cells transfected with the mSIM mutant than in cells transfected with wildtype IE2 (Fig. 2B ). These results demonstrate that the non-covalent SUMO-binding activity of IE2 through a SIM plays an important role in transactivation function.
Growth defects of recombinant viruses encoding mSIM-or KR/mSIM-IE2s.
To evaluate the role of IE2 SIM in viral growth in the context of virus infection, we constructed two Towne-BAC (T-BAC) clones encoding the SIM mutants of IE2 (mSIM and KR/mSIM) and their revertants (Fig. 3A) . Introduction of the desired mutation was confirmed by direct sequencing. Comparison of the restriction enzyme-digested patterns of the wild-type, mutant, and revertant T-BAC clones did not show any apparent alteration of their T-BAC DNAs (Fig. 3B ).
When permissive HF cells were transfected with the BAC DNAs via electroporation, both mSIM and KR/mSIM viruses grew very slowly, compared to wild-type and revertant viruses (Fig. 3C ).
These results suggest that the SIM mutation causes severely defective growth of the Towne virus in We next compared the titers of wild-type, mutant (mSIM, KR, and KR/mSIM) and their revertant viruses produced from infected HF cells. When the total amounts of virus produced (intracellular and extracellular combined) were measured at 5 days after infection with an MOI of 2 or at 9 days after infection with an MOI of 0.1, the titers of mSIM and KR/mSIM viruses were lower by 20-fold at an MOI of 2 and by 10,000-fold at an MOI of 0.1, compared to wild-type and revertant viruses (Fig. 5A ). Consistent with our earlier observation (32), the titers of the KR mutant virus was similar to those of wild-type virus at both MOIs (Fig. 5A) . In immunoblotting assays with cell extracts prepared at the same time points, the mSIM virus showed reduced accumulation of SUMO-modified IE2, p52 (an early protein), and pp28 (a late protein) at both MOIs (Fig. 5B ). For the KR/mSIM virus, as expected, no SUMO-modified IE2 was detected, and the levels of all of IE2, on July 8, 2017 by guest http://jvi.asm.org/ Downloaded from p52, and pp28 proteins were significantly reduced (Fig. 5B) . Importantly, in cells infected at low MOI, both mSIM and KR mutant viruses expressed comparable amounts of unmodified IE2 and little or no SUMO-modified IE2 (Fig. 5B) ; however, the titer of the IE2 SIM mutant was 10,000-fold less than that of the KR-mutant IE2 virus (Fig. 5A) , suggesting that abrogation of SIM rather than SUMOylation has a more profound effect on viral growth in this virus. Two late proteins, p60
and p40, are expressed within exon-5. It has been found that the SIM mutation in the viral genome does not disturb the p60 and p40 initiator methionine residues (located at 170 and 220, respectively) or their upstream TATAA sequences (53). We found that generation of the SIM mutant did not abrogate the expression of the smaller IE2 forms (Fig. 5C ). The reduced virus titers of mSIM and KR/mSIM viruses also correlated well with the slow spread of green fluorescent protein (GFP) signals to neighboring cells (Fig. S2 ).
We further analyzed the growth curves of mSIM virus at high and low MOIs in HF cells.
The results showed that at an MOI of 2, the growth of mSIM virus was delayed 1 or 2 days and the highest titer was 20-fold less than the titers of wild-type and revertant viruses (Fig. 6A, left) . At an MOI of 0.1, the growth of mutant virus was more profoundly delayed, and the maximum titer was 10,000-fold lower than the titers of wild-type and revertant viruses (Fig. 6A, right) . The reduced growth of mSIM virus at an MOI of 2 correlated with the reduced accumulation of SUMO-modified IE2, p52, and pp28 (Fig. 6B, left) . At an MOI of 0.1, the accumulation of all IE1, IE2, p52, and pp28 proteins was more severely reduced in mSIM virus-infected cells (Fig. 6B, right) . Overall, these data demonstrate that the growth defect of mSIM virus is attributed to less efficient accumulation of SUMO-modified IE2 and early and late proteins. This observation is consistent with the reduced transactivation activity of IE2 in the SIM mutant (Fig 2) .
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Reduced formation of viral transcription domains in mSIM virus infection.
We investigated whether the formation of IE2-containing viral transcription domains (4, 24, 59 ) at early times is affected in mSIM virus-infected cells. HF cells were infected with viruses at an MOI of 2, double-labeled for IE2 and PML 8 h after infection, and analyzed using a confocal microscope.
At this time point, wild-type IE2 was localized in viral transcription domains (i.e., as nuclear foci) on the nuclear diffuse background; however, the formation of viral transcription domains was markedly reduced in mSIM virus-infected cells, compared to wild-type and revertant virus infections (Fig. 7A ). In quantitative assays performed at 6, 8, and 10 h after infection, the numbers of IE2 foci produced in mSIM or KR/mSIM virus-infected cells were about 10-fold lower at 6 h compared to wild-type and their revertant viruses, although they reached about 50% of IE2 foci produced in wild-type and revertant viruses by 10 h after infection (Fig. 7B , left graph). The intensity of IE2 foci was also weaker in mSIM virus-infected cells than in wild-type and revertant virus-infected cells (Fig. 7C) . The inefficient targeting of IE2 to viral transcription domains may be attributed to its aberrant localization property as seen in transfected cells (Fig. S1 ). However, when we examined the localization patterns of UL112-113 and HDAC2, which accumulate at viral transcription sites (4, 45), both proteins also accumulated less efficiently at viral transcription domains in mSIM virus-infected cells (Figs. S3 and 2B, right graph). These results suggest that the IE2 SIM is required for efficient targeting of IE2 and other IE2-associated proteins, such as UL112-113 and HDAC2, to viral transcription sites. Consequently, the development of normal-sized viral replication compartments in the infected cell nuclei was also delayed in mSIM virus-infected cells (Fig. S4) .
We next investigated whether the association of IE2 with HCMV major IE (MIE), UL54, (Fig. 7D) . IE2 did not associate with the MIE exon-5 region in a control experiment (Fig. 7D) . This result suggests that the reduced formation of viral transcription domains in mSIM virus may result from the reduced association of IE2 with viral promoters. The minimal region of IE2 for DNA-binding activity is 346-542 (12) . Since the IE2 SIM lies beyond this region, it is unlikely that the mSIM mutation affected the direct DNA binding activity of IE2.
Indeed, the mSIM mutant still autoregulated its own promoter in reporter assays (data not shown).
IE2 interacts with SUMO-modified TAF12 through a SIM, and this interaction contributes to
IE2-mediated transactivation function.
Among general transcription factors, recombinant TBP and TBP-associated factors (TAFs), such as TAF5 and TAF12, have recently been shown to be modified by SUMO (9, 51). TBP has been shown to physically interact with unmodified IE2 (11, 19, 25, 57) . In this study, we investigated the possible association of IE2 with SUMO-modified TAF12. When HF cells were first transfected with hemagglutinin (HA)-tagged wild-type and SUMOylation-defective K19R mutant TAF12, and then infected with HCMV, IE2 was found to form a complex with both wild-type and K19R mutant TAF12 proteins (Fig. 8A) . In similarly transfected and infected cells, both wild-type and mutant TAF12 proteins were shown to be colocalized with IE2 in viral transcription domains, demonstrating that TAF12 recruitment to viral transcription sites is independent of its SUMOylation (Fig. 8B) .
We next investigated whether IE2 physically interacts with intact or SUMO-modified TAF12. Unmodified and SUMO-1-modified forms of His-TAF12 were produced in E. coli and used for in vitro binding assays with IE2 translated in vitro. The results showed that SUMO-modified TAF12, but not unmodified TAF12, interacts with IE2 in an IE2 SIM-dependent manner (Fig. 8C ).
IE2 did not interact with SUMO-modified IE1 under similar experimental conditions (Fig. 8D ).
This suggests that the interaction between IE2 and SUMO-modified TAF12 is either context dependent or the SUMO moiety conjugated to lysine 450 of IE1 is masked from being recognized by IE2. We also used the SUMO-1-TAF12 fusion protein as a surrogate for the SUMO-modified form of TAF12. In GST pull-down assays using bacterially produced GST, GST-TAF12, and GST-SUMO-1-TAF12 proteins, in-vitro-translated IE2 interacted with only GST-SUMO-1-TAF12, but not with GST or GST-TAF12, and mSIM IE2 did not interact with GST-SUMO-1-TAF12 (Fig. 8E) .
Collectively, these in vitro binding assay results demonstrate that IE2 interacts with SUMOmodified TAF12 through a SIM.
To evaluate the role of the interaction between IE2 and SUMO-modified TAF12 in IE2 transactivation function, we performed reporter assays in HF cells using a viral DNA polymerase (UL54)-luciferase reporter construct. The results showed that the IE2-mediated transactivation capacity for polymerase promoter under TAF12-overexpressing conditions was 50% less when a SUMOylation-defective K19R mutant was used instead of wild-type TAF12; however, the transactivation activity mediated by mSIM IE2 was similar in both wild-type and K19R-mutant TAF12-expressing cells (Fig. 9A) . We also measured the effect of the interaction between IE2 and SUMO-modified TAF12 on the activation of the polymerase promoter in virus-infected cells. When wild-type TAF12 than in cells with the K19R mutant, and the transactivation activity of IE2 was higher in cells expressing SUMO-1-TAF12 fusion protein than in cells expressing wild-type TAF12 (Fig. 9B) .
To investigate the role of the interaction between IE2 and SUMO-modified TAF12 in virus infected cells, control HF cells and cells expressing the SUMO-TAF12 fusion protein were infected with wild-type, mSIM, and mSIM-R viruses, and the expression level of p52 (UL44) was examined.
The results showed that the p52 levels in wild-type and mSIM-R virus infection were increased in cells expressing the SUMO-1-TAF12 fusion protein compared to those in control cells, but the p52 level in mSIM virus infection was not increased in SUMO-1-TAF12-expressing cells (Fig. 9C ).
These results suggest that the interaction of IE2 with SUMO-modified TAF12 contributes to the transactivation function of IE2 in virus-infected cells. The possible role of non-covalent interaction of IE2 with SUMO-modified TAF12 and its covalent SUMO modification in enhancing the formation of the IE2-containing transcription initiation complex is illustrated in Fig. 9D .
DISCUSSION
In this study, we provide evidence that non-covalent SUMO-binding activity of IE2 plays by non-covalent SUMO binding through a SIM (7, 28) . In our study, the SUMO-modified IE2
consistently accumulated less efficiently in IE2 SIM mutant virus-infected cells (Figs. 5 and 6 ).
Although SUMOylation of IE2 enhances its transactivation activity, and the IE2 SIM is necessary for efficient SUMOylation of IE2, it is unlikely that the reduced transactivation activity of the mSIM IE2 is solely attributed to the reduction of IE2 SUMOylation. In our reporter assays performed under the conditions without SUMO overexpression, the IE2 KR mutant, which is defective in SUMOylation, had transactivation activity similar to wild-type IE2; however, under the same conditions, the IE2 SIM mutant showed significantly reduced transactivation activity compared to wild-type. Therefore, non-covalent SUMO binding by IE2 is also able to promote IE2 transactivation function in a manner independent of the degree of IE2 SUMOylation. In this regard, it is notable that the minimum IE2 region required for transactivation functioning, which was determined by reporter assays, includes the SIM, but not the SUMO conjugation site (Fig. 1A ).
Our analysis of the growth characteristics of recombinant viruses clearly demonstrate that the SIM mutant viruses (both mSIM and mSIM/KR viruses) have severely defective growth at both high and low MOIs, indicating the important role of the IE2 SIM in the promotion of viral growth.
In addition to reduced transactivation activity in reporter assays, the less efficient formation of viral transcription domains and the reduced association of the mSIM IE2 with viral promoters in mutant virus-infected cells (Fig. 7) may account for defective growth by the mSIM IE2 viruses. As seen by the failure of the mSIM IE2 to target to PML-NBs in transfected cells (Fig. S1 ), the IE2 SIM is The 72-kD IE1 protein is also covalently modified by SUMO (61, 67) . Interestingly, we
found that the accumulation levels of the SUMO-modified form of IE1 in infected cells were generally higher at low MOI than at high MOI, and in cells infected with SIM mutant virus than with wild-type virus (Fig. 5B ). This suggests that the level of IE1 SUMOylation may be regulated on July 8, 2017 by guest
